Tobacco use and bladder cancer patterns in three western European countries

Journal of Public Health

Volumn 31, Issue 3, 2009, Pages 335-344

  Van Hemelrijck, Mieke J J ^a,b   Michaud, Dominique S ^a,c   Connolly, Gregory N ^a   Kabir, Zubair ^a,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d Research Institute for a Tobacco Free Society   (Ireland)

Author keywords

Bladder cancer incidence; Europe; Joinpoint analysis; Secondhand smoking; Tobacco

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER TUMOR; CONFIDENCE INTERVAL; FEMALE; HUMAN; INCIDENCE; LUNG TUMOR; MALE; MIDDLE AGED; MORTALITY; PASSIVE SMOKING; PREVALENCE; REGRESSION ANALYSIS; SEX DIFFERENCE; SMOKING; SPAIN; SWEDEN; UNITED KINGDOM;

ADULT; AGE DISTRIBUTION; AGED; CONFIDENCE INTERVALS; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS; SEX FACTORS; SMOKING; SPAIN; SWEDEN; TOBACCO SMOKE POLLUTION; URINARY BLADDER NEOPLASMS;

EID: 70349573524     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/pubmed/fdp062     Document Type: Article

References (38)

1. Silverman D, Devesa S, Moore L et al. Bladder cancer. In: Schottenfeld D, Fraumeni J (eds). Cancer Epidemiology and Prevention. Oxford: Oxford University press, 2006.
2. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP et al. Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol 2007;25:285-295
3. Bjerregaard BK, Raaschou-Nielsen O, Sorensen M et al. Tobacco smoke and bladder cancer-in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2006;119:2412-2416
4. Pitard A, Brennan P, Clavel J et al. Cigar, pipe, and cigarette smoking and bladder cancer risk in European men. Cancer Causes Control 2001;12:551-556
5. Samanic C, Kogevinas M, Dosemeci M et al. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev 2006;15:1348-1354
6. Martone T, Airoldi L, Magagnotti C et al. 4-Aminobiphenyl-DNA adducts and p53 mutations in bladder cancer. Int J Cancer 1998;75:512-516
7. Vineis P, Caporaso N. Tobacco and cancer: epidemiology and the laboratory. Environ Health Perspect 1995;103:156-160
8. Landi MT, Zocchetti C, Bernucci I et al. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels. Cancer Epidemiol Biomarkers Prev 1996;5:693-698
9. Saletta F, Matullo G, Manuguerra M et al. Exposure to the tobacco smoke constituent 4-aminobiphenyl induces chromosomal instability in human cancer cells. Cancer Res 2007;67:7088-7094
10. Vineis P, Pirastu R. Aromatic amines and cancer. Cancer Causes Control 1997;8:346-355
11. Bartsch H, Malaveille C, Friesen M et al. Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur J Cancer 1993;29A:1199-1207
12. Malaveille C, Vineis P, Esteve J et al. Levels of mutagens in the urine of smokers of black and blond tobacco correlate with their risk of bladder cancer. Carcinogenesis 1989;10:577-586
13. Vineis P. The use of biomarkers in epidemiology: the example of bladder cancer. Toxicol Lett 1992;64-65:463-467
14. Hammond SK, Coghlin J, Gann PH et al. Relationship between environmental tobacco smoke exposure and carcinogenhemoglobin adduct levels in nonsmokers. J Natl Cancer Inst 1993;85:474-478
15. Van Hemelrijck MJ, Michaud DS, Connolly GN et al. Secondhand smoking, 4-aminobiphenyl, and bladder cancer: two meta-analyses. Cancer Epidemiol Biomarkers Prev 2009;18:1312-1320
16. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005;16:481-488
17. Mackay J, Eriksen M, Shafey O. The Tobacco Atlas. Georgia: American Cancer Society, 2006.
18. The ASPECT Consortium. Tobacco or Health in the European Union: Past, Present and Future. Luxembourg: Office for Official Publications of the European Communities, 2004.
19. Van Hemelrijck MJ, Kabir Z, Connolly GN. Trends in lung cancer death rates in Belgium and The Netherlands: a systematic analysis of temporal patterns. J Community Health 2009;34: 188-194
20. Parkin D, Whelan S, Ferlay J et al. Cancer Incidence in Five Continents, Vol.I to VIII. International Agency for Research on Cancer: Cancer Base 7, 2005.
21. Hartge P, Hoover R, Kantor A. Bladder cancer risk and pipes, cigars, and smokeless tobacco. Cancer 1985;55:901-906
22. Forey B, Hamling J, Lee P et al. International Smoking Statistics. London: Oxford University Press, 2003.
23. World Health Organization. Tobacco Control Database. Geneva: WHO Regional Office for Europe, 2007.
24. Ezzati M, Lopez D. Smoking and oral tobacco use. Comparative Quantification of Health Risks Global and Regional Burden of Disease Attributable to Selected Major Risk Factor. Geneva: World Health Organization, 2004.
25. Ferlay J. World Health Organization's Mortality Database. Descriptive Epidemiology Group, Biostatistics and Epidemiology Cluster International Agency for Research on Cancer. 2007.
26. Jemal A, Cokkinides VE, Shafey O et al. Lung cancer trends in young adults: an early indicator of progress in tobacco control (United States). Cancer Causes Control 2003;14:579-585
27. World Health Organization. International Statistical Classification of Disease and Related Health Problems. Geneva: World Health Organization, 1992.
28. Mazzone P, Obuchowski N, Mekhail T et al. Lung cancer screening: is it time for a change in policy? Cleve Clin J Med 2007;74: 441-448
29. Bosetti C, Levi F, Lucchini F et al. Lung cancer mortality in European women: recent trends and perspectives. Ann Oncol 2005;16:1597-1604
30. Kabir Z, Connolly GN, Clancy L. Temporal patterns in lung cancer death rates in Ireland. Ir J Med Sci 2007;176:81-85
31. Levi F, Bosetti C, Fernandez E et al. Trends in lung cancer among young European women: the rising epidemic in France and Spain. Int J Cancer 2007;121:462-465
32. Kogevinas M, Trichopoulos D. Bladder cancer. Textbook of Cancer Epidemiology. London: Oxford University Press, 2002.
33. Melikian AA, Djordjevic MV, Hosey J et al. Gender differences relative to smoking behavior and emissions of toxins from mainstream cigarette smoke. Nicotine Tob Res 2007;9:377-387
34. Michaud DS, Clinton SK, Rimm EB et al. Risk of bladder cancer by geographic region in a U.S. cohort of male health professionals. Epidemiology 2001;12:719-726
35. Foulds J, Ramstrom L, Burke M et al. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control 2003;12:349-359
36. Rodu B, Stegmayr B, Nasic S et al. Evolving patterns of tobacco use in northern Sweden. J Intern Med 2003;253:660-665
37. Slattery ML, Schumacher MC, West DW et al. Smoking and bladder cancer. The modifying effect of cigarettes on other factors. Cancer 1988;61:402-408
38. Morgenstern H. Ecologic studies. In: Rothman K, Greenland S (eds). Modern Epidemiology, 2nd Edn. Philadelphia: Lipincott Williams & Wilkins, 1998.